98
Views
4
CrossRef citations to date
0
Altmetric
Articles

Progressive capillary loss over a decade in patients with systemic sclerosis, in particular in patients with early digital ischaemic manifestations

, , &
Pages 457-461 | Accepted 19 Jun 2011, Published online: 21 Sep 2011

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

CZ Camargo, JY Sekiyama, MI Arismendi & C Kayser. (2015) Microvascular abnormalities in patients with early systemic sclerosis: less severe morphological changes than in patients with definite disease. Scandinavian Journal of Rheumatology 44:1, pages 48-55.
Read now

Articles from other publishers (3)

Marie Wildt, Kristofer Andréasson, Viggo Hamberg, Roger Hesselstrand & Dirk M Wuttge. (2023) Treatment with mycophenolate mofetil is associated with improved nailfold vasculature in systemic sclerosis. Rheumatology.
Crossref
A. Sulli, B. Ruaro, V. Smith, S. Paolino, C. Pizzorni, G. Pesce & M. Cutolo. (2017) Subclinical dermal involvement is detectable by high frequency ultrasound even in patients with limited cutaneous systemic sclerosis. Arthritis Research & Therapy 19:1.
Crossref
Agustin Cornejo, Keith C. Neaman, Ramesh C. Srinivasan, Suhail K. Mithani & William C. Pederson. (2016) In Situ Venous Bypass for Chronic Hand Ischemia. Annals of Plastic Surgery 76:Supplement 4, pages S275-S279.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.